Randomized trial of hyperthermia and radiation for superficial tumors
/in Breast Cancer, Hyperthermia, International Publications, Malignant Melanoma /von 2005-05-01 / J. Clin. Oncol. 2005 May;23(13):3079-85Emerging evidence indicates that physiologically relevant thermal stress regulates dendritic cell function
/in Dendritic Cells, Hyperthermia, International Publications /von 2005-04-28 / Cancer Immunol. Immunother. 2006 Mar;55(3):292-8Phase I study of immunization with dendritic cells modified with fowlpox encoding carcinoembryonic antigen and costimulatory molecules
/in Colorectal Cancer, International Publications /von 2005-04-15 / Clin. Cancer Res. 2005 Apr;11(8):3017-24Maturation requirements for dendritic cells in T cell stimulation leading to tolerance versus immunity
/in Dendritic Cells, International Publications /von 2005-04-04 / J. Leukoc. Biol. 2005 Aug;78(2):319-24Targeting vaccinia to solid tumors with local hyperthermia
/in Hyperthermia, International Publications, Newcastle Disease Virus /von 2005-04-01 / Hum. Gene Ther. 2005 Apr;16(4):435-44Tumor lysate and IL-18 loaded dendritic cells elicits Th1 response, tumor-specific CD8+ cytotoxic T cells in patients with malignant glioma
/in Dendritic Cells, Glioblastoma, International Publications /von 2005-04-01 / J. Neurooncol. 2005 Apr;72(2):107-13T-cell triggering by CD3- and CD28-binding molecules linked to a human virus-modified tumor cell vaccine
/in International Publications, Newcastle Disease Virus /von 2005-03-31 / Vaccine 2005 Mar;23(19):2439-53Therapeutic effect of autologous dendritic cell vaccine on patients with chronic hepatitis B: a clinical study
/in Chronic Virus Hepatitis, International Publications /von 2005-03-28 / World J. Gastroenterol. 2005 Mar;11(12):1806-8Tumour-dendritic hybrid cell vaccination for the treatment of patients with malignant melanoma: immunological effects and clinical results
/in International Publications, Malignant Melanoma /von 2005-03-18 / Vaccine 2005 Mar;23(17-18):2367-73IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de